Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

Overview of attention for article published in Health Economics Review, September 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 18,771 followers.

RT @HIV_Insight: Cost Analysis of HIV Tx & Drug-Related Adverse Events When Fixed-Dose Combo of ARV were Stopped... http://t.co/mi8OZLHG

RT @HIV_Insight: Cost Analysis of HIV Tx & Drug-Related Adverse Events When Fixed-Dose Combo of ARV were Stopped... http://t.co/mi8OZLHG

Cost Analysis of HIV Tx & Drug-Related Adverse Events When Fixed-Dose Combo of ARV were Stopped... http://t.co/mi8OZLHG

Cost Analysis of HIV Tx & Drug-Related Adverse Events When Fixed-Dose Combo of ARV were Stopped... http://t.co/G9KeW1ZM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.